查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1609189

核酸样品製备市场：按产品、应用和最终用户 - 2025-2030 年全球预测

Nucleic Acid Sample Preparation Market by Product (Accessories, Consumables, Sample Preparation Instruments), Application (Epigenomics, Genomics, Proteomics), End-user - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 199 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年核酸样品製备市场价值为45.2亿美元，预计到2024年将达到50.3亿美元，复合年增长率为9.11%，到2030年将达到83.2亿美元。

核酸样品製备是从各种生物样本中萃取和精製DNA 和 RNA，是诊断学、基因组学和个人化医疗等下游应用的关键步骤。此过程的需求在于其提供高品质核酸的能力，这对于在定序技术、聚合酵素链锁反应(PCR) 和其他分析程序中获得准确结果至关重要。其应用涵盖实验室、临床诊断、製药和生物技术领域。该市场的成长是由基因组技术的进步、研发资金的增加以及遗传和感染疾病患者病率的上升所推动的。然而，先进技术的高成本、监管限制和技术力等挑战可能会阻碍市场成长。

主要市场统计
基准年[2023] 45.2亿美元
预测年份 [2024] 50.3亿美元
预测年份 [2030] 83.2亿美元
复合年增长率（%） 9.11%

影响成长的关键因素包括在样品製备系统中更多地采用自动化以提高通量和准确性，以及微流体技术的整合以实现小型化和加速。新的商机在于开发用户友好的就地检验套件和可携式解决方案，例如用于分散和特定地点应用的实验室晶片实验室设备。公司可以透过投资研发来利用这些机会，创造具有成本效益的高功率技术。然而，市场相关人员必须克服挑战，例如严格的监管环境和适应快速发展的技术的需要。

创新和研究应着重于提高样品製备技术的效率和多功能性，以及开发永续和环境友善的方法。此外，探索与人工智慧的协同效应可以优化工作流程管理和资料分析，从而提供竞争优势。核酸样品製备市场的本质是动态和竞争的，其特点是技术快速进步和不断变化的客户需求。企业必须保持敏捷和知情，以便利用成长动力，同时积极解决阻碍因素，以确保永续发展和强大的市场地位。

市场动态：揭示快速发展的核酸样品製备市场的关键市场洞察

供需的动态交互作用正在改变核酸样品製备市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时也能帮助消费行为及其对製造业的影响。

  • 市场驱动因素
    • 全球感染疾病流行
    • 扩大核酸分子在治疗领域的用途
  • 市场限制因素
    • 检测试剂高成本，医疗专业人员缺乏标准化培训
  • 市场机会
    • 扩大自动核酸萃取技术的采用
    • 核酸样品製备新技术进展
  • 市场挑战
    • 与核酸样本相关的伦理问题

波特五力：开拓核酸样品製备市场的策略工具

波特的五力框架是了解核酸样品製备市场竞争格局的关键工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解核酸样品製备市场的外部影响

外部宏观环境因素在塑造核酸样品製备市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解核酸样本製备市场的竞争格局

对核酸样品製备市场的详细市场占有率分析可以对供应商绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV定位矩阵核酸样本製备市场供应商绩效评估

FPNV定位矩阵是评估核酸样本製备市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议描绘了核酸样品製备市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，对核酸样品製备市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点关注可望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 感染疾病在世界各地的传播加剧
      • 扩大核酸分子在治疗领域的用途
    • 抑制因素
      • 检测试剂成本高，医疗专业人员缺乏标准化培训
    • 机会
      • 更多采用自动化核酸萃取技术
      • 核酸样品製备新技术进展
    • 任务
      • 与核酸样本相关的伦理问题
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章核酸样品製备市场：副产品

  • 配件
  • 消耗品
  • 样品製备设备

第七章核酸样品製备市场：依应用分类

  • 表观基因
  • 基因组学
  • 蛋白质体学

第八章核酸样品製备市场：依最终使用者分类

  • 学术/研究机构
  • 临床和诊断实验室
  • 製药和生物技术公司

第九章美洲核酸样本製备市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十章亚太地区核酸样本製备市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章 欧洲、中东和非洲核酸样本製备市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Agilent Technologies, Inc.
  • Aurora Biomed Inc.
  • BGI Group
  • Bio-Rad Laboratories, Inc.
  • Bionano Genomics
  • BIONEER CORPORATION
  • Blue-Ray Biotech Corp.
  • Danaher Corporation
  • Eppendorf SE
  • F. Hoffmann-La Roche Ltd
  • Hamilton Company
  • Illumina, Inc.
  • LGC Biosearch Technologies
  • Merck KGaA
  • MP Biomedicals, LLC
  • Nanjing Vazyme Biotech Co.,Ltd.
  • Norgen Biotek Corp.
  • Opentrons Labworks, Inc.
  • PerkinElmer Inc.
  • Promega Corporation
  • QIAGEN NV
  • RevoluGen Ltd
  • Sansure Biotech Inc.
  • Tecan Trading AG
  • Thermo Fisher Scientific Inc.
Product Code: MRR-5C6F41F5B02F

The Nucleic Acid Sample Preparation Market was valued at USD 4.52 billion in 2023, expected to reach USD 5.03 billion in 2024, and is projected to grow at a CAGR of 9.11%, to USD 8.32 billion by 2030.

Nucleic acid sample preparation involves the extraction and purification of DNA or RNA from various biological samples, a crucial step for downstream applications in diagnostics, genomics, and personalized medicine. The necessity of this process lies in its ability to provide high-quality nucleic acids, essential for accurate results in sequencing technologies, polymerase chain reactions (PCR), and other analytical procedures. Its application spans research laboratories, clinical diagnostics, pharmaceuticals, and biotechnology sectors. The growth of this market is propelled by advancements in genomic technologies, increased funding for research and development, and the rising prevalence of genetic disorders and infectious diseases. However, challenges such as high costs of advanced technologies, regulatory constraints, and technical competencies may hinder market growth.

KEY MARKET STATISTICS
Base Year [2023] USD 4.52 billion
Estimated Year [2024] USD 5.03 billion
Forecast Year [2030] USD 8.32 billion
CAGR (%) 9.11%

Key influencing growth factors include the increased adoption of automation in sample preparation systems, which enhances throughput and accuracy, and the integration of microfluidic technologies that enable miniaturization and speed. Emerging opportunities lie in the development of user-friendly kits for point-of-care testing and portable solutions like lab-on-a-chip devices, catering to decentralized and field-specific applications. Companies can capitalize on these opportunities by investing in R&D to create cost-effective and high-output technologies. Nonetheless, market players must navigate challenges such as strict regulatory landscapes and the need for adaptation to rapidly evolving technologies.

Innovation and research should focus on improving the efficiency and versatility of sample preparation techniques, alongside developing sustainable and eco-friendly approaches. Additionally, exploring synergies with artificial intelligence can optimize workflow management and data analysis, offering competitive advantages. The nature of the nucleic acid sample preparation market is dynamic and competitive, characterized by rapid technological advancements and evolving customer requirements. Businesses must remain agile and informed to capitalize on growth drivers while proactively addressing constraints, ensuring sustainable development and robust market positioning.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Nucleic Acid Sample Preparation Market

The Nucleic Acid Sample Preparation Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing prevalence of infectious disease worldwide
    • Growing use of nucleic acid molecule in therapeutic areas
  • Market Restraints
    • High cost associated with detection reagent and lack of standardized training for health professional
  • Market Opportunities
    • Growing adoption of automated nucleic acid extraction techniques
    • New technological advancements in nucleic acid sample preparation
  • Market Challenges
    • Ethical concerns associated with nucleic acid sample

Porter's Five Forces: A Strategic Tool for Navigating the Nucleic Acid Sample Preparation Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Nucleic Acid Sample Preparation Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Nucleic Acid Sample Preparation Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Nucleic Acid Sample Preparation Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Nucleic Acid Sample Preparation Market

A detailed market share analysis in the Nucleic Acid Sample Preparation Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Nucleic Acid Sample Preparation Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Nucleic Acid Sample Preparation Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Nucleic Acid Sample Preparation Market

A strategic analysis of the Nucleic Acid Sample Preparation Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Nucleic Acid Sample Preparation Market, highlighting leading vendors and their innovative profiles. These include Agilent Technologies, Inc., Aurora Biomed Inc., BGI Group, Bio-Rad Laboratories, Inc., Bionano Genomics, BIONEER CORPORATION, Blue-Ray Biotech Corp., Danaher Corporation, Eppendorf SE, F. Hoffmann-La Roche Ltd, Hamilton Company, Illumina, Inc., LGC Biosearch Technologies, Merck KGaA, MP Biomedicals, LLC, Nanjing Vazyme Biotech Co.,Ltd., Norgen Biotek Corp., Opentrons Labworks, Inc., PerkinElmer Inc., Promega Corporation, QIAGEN N.V., RevoluGen Ltd, Sansure Biotech Inc., Tecan Trading AG, and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the Nucleic Acid Sample Preparation Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Accessories, Consumables, and Sample Preparation Instruments.
  • Based on Application, market is studied across Epigenomics, Genomics, and Proteomics.
  • Based on End-user, market is studied across Academic & Research Institutions, Clinical & Diagnostic Laboratories, and Pharmaceutical & Biotechnology Companies.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalence of infectious disease worldwide
      • 5.1.1.2. Growing use of nucleic acid molecule in therapeutic areas
    • 5.1.2. Restraints
      • 5.1.2.1. High cost associated with detection reagent and lack of standardized training for health professional
    • 5.1.3. Opportunities
      • 5.1.3.1. Growing adoption of automated nucleic acid extraction techniques
      • 5.1.3.2. New technological advancements in nucleic acid sample preparation
    • 5.1.4. Challenges
      • 5.1.4.1. Ethical concerns associated with nucleic acid sample
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Nucleic Acid Sample Preparation Market, by Product

  • 6.1. Introduction
  • 6.2. Accessories
  • 6.3. Consumables
  • 6.4. Sample Preparation Instruments

7. Nucleic Acid Sample Preparation Market, by Application

  • 7.1. Introduction
  • 7.2. Epigenomics
  • 7.3. Genomics
  • 7.4. Proteomics

8. Nucleic Acid Sample Preparation Market, by End-user

  • 8.1. Introduction
  • 8.2. Academic & Research Institutions
  • 8.3. Clinical & Diagnostic Laboratories
  • 8.4. Pharmaceutical & Biotechnology Companies

9. Americas Nucleic Acid Sample Preparation Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Nucleic Acid Sample Preparation Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Nucleic Acid Sample Preparation Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Agilent Technologies, Inc.
  • 2. Aurora Biomed Inc.
  • 3. BGI Group
  • 4. Bio-Rad Laboratories, Inc.
  • 5. Bionano Genomics
  • 6. BIONEER CORPORATION
  • 7. Blue-Ray Biotech Corp.
  • 8. Danaher Corporation
  • 9. Eppendorf SE
  • 10. F. Hoffmann-La Roche Ltd
  • 11. Hamilton Company
  • 12. Illumina, Inc.
  • 13. LGC Biosearch Technologies
  • 14. Merck KGaA
  • 15. MP Biomedicals, LLC
  • 16. Nanjing Vazyme Biotech Co.,Ltd.
  • 17. Norgen Biotek Corp.
  • 18. Opentrons Labworks, Inc.
  • 19. PerkinElmer Inc.
  • 20. Promega Corporation
  • 21. QIAGEN N.V.
  • 22. RevoluGen Ltd
  • 23. Sansure Biotech Inc.
  • 24. Tecan Trading AG
  • 25. Thermo Fisher Scientific Inc.

LIST OF FIGURES

  • FIGURE 1. NUCLEIC ACID SAMPLE PREPARATION MARKET RESEARCH PROCESS
  • FIGURE 2. NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. NUCLEIC ACID SAMPLE PREPARATION MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. NUCLEIC ACID SAMPLE PREPARATION MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. NUCLEIC ACID SAMPLE PREPARATION MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. NUCLEIC ACID SAMPLE PREPARATION MARKET DYNAMICS
  • TABLE 7. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY ACCESSORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY SAMPLE PREPARATION INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY EPIGENOMICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY GENOMICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY PROTEOMICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY CLINICAL & DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 26. BRAZIL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 27. BRAZIL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 28. BRAZIL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 29. CANADA NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 30. CANADA NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 31. CANADA NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 32. MEXICO NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 33. MEXICO NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 34. MEXICO NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 38. UNITED STATES NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 42. ASIA-PACIFIC NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 43. AUSTRALIA NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 44. AUSTRALIA NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 45. AUSTRALIA NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 46. CHINA NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 47. CHINA NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 48. CHINA NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 49. INDIA NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 50. INDIA NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 51. INDIA NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 52. INDONESIA NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 53. INDONESIA NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 54. INDONESIA NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 55. JAPAN NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 56. JAPAN NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. JAPAN NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 58. MALAYSIA NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 59. MALAYSIA NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 60. MALAYSIA NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 61. PHILIPPINES NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 62. PHILIPPINES NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 63. PHILIPPINES NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 64. SINGAPORE NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 65. SINGAPORE NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. SINGAPORE NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 67. SOUTH KOREA NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 68. SOUTH KOREA NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. SOUTH KOREA NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 70. TAIWAN NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 71. TAIWAN NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 72. TAIWAN NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 73. THAILAND NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 74. THAILAND NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. THAILAND NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 76. VIETNAM NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 77. VIETNAM NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. VIETNAM NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 83. DENMARK NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 84. DENMARK NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 85. DENMARK NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 86. EGYPT NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 87. EGYPT NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 88. EGYPT NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 89. FINLAND NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 90. FINLAND NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 91. FINLAND NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 92. FRANCE NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 93. FRANCE NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. FRANCE NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 95. GERMANY NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 96. GERMANY NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. GERMANY NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 98. ISRAEL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 99. ISRAEL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 100. ISRAEL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 101. ITALY NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 102. ITALY NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 103. ITALY NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 104. NETHERLANDS NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 105. NETHERLANDS NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 106. NETHERLANDS NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 107. NIGERIA NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 108. NIGERIA NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 109. NIGERIA NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 110. NORWAY NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 111. NORWAY NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 112. NORWAY NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 113. POLAND NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 114. POLAND NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 115. POLAND NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 116. QATAR NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 117. QATAR NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 118. QATAR NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 119. RUSSIA NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 120. RUSSIA NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 121. RUSSIA NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 122. SAUDI ARABIA NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 123. SAUDI ARABIA NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 124. SAUDI ARABIA NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH AFRICA NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH AFRICA NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH AFRICA NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 128. SPAIN NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 129. SPAIN NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 130. SPAIN NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 131. SWEDEN NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 132. SWEDEN NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 133. SWEDEN NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 134. SWITZERLAND NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 135. SWITZERLAND NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 136. SWITZERLAND NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 137. TURKEY NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 138. TURKEY NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 139. TURKEY NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED ARAB EMIRATES NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED ARAB EMIRATES NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED ARAB EMIRATES NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED KINGDOM NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED KINGDOM NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED KINGDOM NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 146. NUCLEIC ACID SAMPLE PREPARATION MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 147. NUCLEIC ACID SAMPLE PREPARATION MARKET, FPNV POSITIONING MATRIX, 2023